Spotlight: Cryoablation therapy used to treat phantom limb pain

spotlight

In a small study involving 20 patients, a team at Emory University says they successfully used cryoablation therapy--cold blasts--to successfully treat phantom limb pain. "Until now, individuals with phantom limb pain have had few medical interventions available to them that resulted in significant reduction in their pain," said Dr. J. David Prologo, an assistant professor in the division of interventional radiology at Emory University School of Medicine. "Now, with the promise of cryoablation, these individuals have a viable treatment option to target this lingering side effect of amputation--a condition that was previously largely untreatable." Release

> Researchers have developed a microscope that can observe and manipulate neural activity in the brains of live animals at the scale of a single cell with millisecond precision. Release

> A new study involving UT Southwestern Medical Center emergency physicians and Dallas-Fort Worth Emergency Medical Services agencies asserts that giving "heart resuscitation drugs to patients whose cardiac arrest is witnessed at the time of the attack can improve survival, but needs to be done through an IV line rather than directly into bone marrow as is more commonly done by paramedics." Release

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Suggested Articles

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.

A new map of the thymus gland could help researchers understand how T cells develop and inspire treatments for cancer and autoimmune disease.

Brigham and Women’s Hospital scientists linked a noncoding RNA to atherosclerosis in a discovery that could aid in the development of new heart drugs.